The University of Chicago Header Logo

Ezra Cohen

Concepts (656)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
122
2024
1062
19.150
Why?
Carcinoma, Squamous Cell
89
2024
1095
13.630
Why?
Antineoplastic Combined Chemotherapy Protocols
59
2023
2550
5.700
Why?
Antineoplastic Agents
50
2024
2410
5.680
Why?
Neoplasm Recurrence, Local
45
2022
1354
5.410
Why?
Quinazolines
28
2019
221
5.080
Why?
ErbB Receptors
29
2021
500
4.290
Why?
Thyroid Neoplasms
16
2024
424
3.990
Why?
Protein Kinase Inhibitors
27
2024
602
3.840
Why?
Mouth Neoplasms
17
2024
198
3.400
Why?
Antibodies, Monoclonal, Humanized
25
2024
967
2.810
Why?
Chemoradiotherapy
21
2022
309
2.710
Why?
Cetuximab
15
2022
117
2.520
Why?
Neoplasms
25
2023
3020
1.870
Why?
Humans
216
2024
88852
1.860
Why?
Disease-Free Survival
36
2021
1213
1.800
Why?
Papillomavirus Infections
10
2022
261
1.760
Why?
Biomarkers, Tumor
16
2020
1532
1.720
Why?
Indazoles
8
2015
67
1.710
Why?
B7-H1 Antigen
10
2024
272
1.700
Why?
Oropharyngeal Neoplasms
6
2018
132
1.660
Why?
Imidazoles
8
2015
148
1.640
Why?
Immunotherapy
11
2024
664
1.600
Why?
Aged
94
2024
19019
1.520
Why?
Methotrexate
9
2019
250
1.460
Why?
Sirolimus
8
2018
170
1.460
Why?
TOR Serine-Threonine Kinases
10
2021
185
1.430
Why?
Carcinoma, Non-Small-Cell Lung
10
2024
1113
1.410
Why?
Programmed Cell Death 1 Receptor
9
2024
169
1.370
Why?
Lung Neoplasms
12
2024
2344
1.350
Why?
Middle Aged
94
2024
25787
1.340
Why?
Antineoplastic Agents, Immunological
7
2020
195
1.290
Why?
Indoles
9
2016
312
1.290
Why?
Anilides
6
2016
48
1.280
Why?
Female
115
2024
45899
1.270
Why?
Pyridines
8
2016
315
1.200
Why?
Treatment Outcome
54
2021
8178
1.190
Why?
Male
106
2024
42135
1.180
Why?
Molecular Targeted Therapy
12
2024
285
1.130
Why?
Adult
81
2024
26439
1.120
Why?
Aged, 80 and over
44
2021
6758
1.120
Why?
Protein-Tyrosine Kinases
6
2012
307
1.050
Why?
Neoplasm Staging
26
2019
1989
1.030
Why?
Neoplasm Metastasis
21
2021
1107
1.020
Why?
Quality of Life
13
2021
1661
0.990
Why?
Cisplatin
9
2022
617
0.970
Why?
Papillomaviridae
8
2024
156
0.920
Why?
Combined Modality Therapy
25
2020
1708
0.900
Why?
Drug Resistance, Neoplasm
7
2019
615
0.900
Why?
Induction Chemotherapy
11
2021
149
0.890
Why?
Everolimus
4
2022
40
0.880
Why?
Fluorocarbons
1
2023
72
0.860
Why?
Mutation
20
2024
4121
0.850
Why?
Salivary Gland Neoplasms
4
2020
67
0.840
Why?
Proto-Oncogene Proteins c-akt
7
2016
340
0.790
Why?
Skin Neoplasms
3
2022
578
0.780
Why?
Phenylurea Compounds
6
2015
114
0.770
Why?
Survival Analysis
20
2020
1533
0.770
Why?
Carcinoma, Papillary
4
2016
159
0.750
Why?
Disease Management
4
2021
328
0.740
Why?
Antibodies, Monoclonal
10
2021
1399
0.730
Why?
Precancerous Conditions
5
2024
200
0.710
Why?
Cell Line, Tumor
16
2021
2549
0.700
Why?
Laryngeal Neoplasms
4
2013
89
0.690
Why?
Nasopharyngeal Neoplasms
3
2015
47
0.690
Why?
Prognosis
21
2021
3757
0.680
Why?
Cancer Vaccines
1
2020
160
0.660
Why?
Vascular Endothelial Growth Factor A
6
2023
420
0.660
Why?
Signal Transduction
17
2021
3370
0.650
Why?
Antigens, Neoplasm
1
2020
332
0.630
Why?
Angiogenesis Inhibitors
8
2023
315
0.630
Why?
Kaplan-Meier Estimate
9
2018
858
0.630
Why?
Human papillomavirus 16
4
2019
38
0.630
Why?
Benzazepines
1
2018
64
0.630
Why?
Proto-Oncogene Proteins c-kit
2
2015
80
0.610
Why?
Quinolines
2
2015
91
0.590
Why?
Survivors
2
2016
233
0.590
Why?
Clinical Trials as Topic
10
2016
1146
0.580
Why?
Fluorouracil
15
2014
561
0.580
Why?
Patient Selection
8
2021
681
0.570
Why?
Killer Cells, Natural
2
2017
275
0.570
Why?
Research Design
5
2014
597
0.560
Why?
Survival Rate
12
2016
1881
0.560
Why?
Precision Medicine
4
2021
408
0.550
Why?
Hypopharyngeal Neoplasms
2
2013
15
0.540
Why?
Carcinoma, Adenoid Cystic
2
2015
31
0.540
Why?
Tumor Microenvironment
7
2024
458
0.540
Why?
Iodine Radioisotopes
5
2023
134
0.530
Why?
Dasatinib
1
2015
37
0.530
Why?
Erlotinib Hydrochloride
6
2016
90
0.510
Why?
Drug Administration Schedule
8
2018
894
0.510
Why?
Mice, Nude
8
2016
814
0.510
Why?
Antibody-Dependent Cell Cytotoxicity
1
2015
22
0.510
Why?
Practice Guidelines as Topic
4
2019
1040
0.500
Why?
Glutamates
2
2012
89
0.500
Why?
Anticarcinogenic Agents
2
2016
73
0.490
Why?
Aftercare
1
2016
87
0.490
Why?
Antibiotics, Antineoplastic
2
2012
116
0.490
Why?
Maximum Tolerated Dose
10
2017
272
0.480
Why?
Adaptor Proteins, Signal Transducing
4
2016
311
0.480
Why?
Receptors, Vascular Endothelial Growth Factor
6
2023
72
0.470
Why?
Guanine
2
2012
207
0.470
Why?
Palliative Care
2
2015
263
0.460
Why?
Radiodermatitis
1
2013
10
0.460
Why?
Mucositis
1
2013
18
0.450
Why?
Neovascularization, Pathologic
3
2015
363
0.450
Why?
Administration, Oral
9
2017
682
0.450
Why?
Pyrroles
4
2015
187
0.450
Why?
Neoplasm Invasiveness
4
2012
575
0.450
Why?
Radiopharmaceuticals
2
2015
193
0.440
Why?
Food-Drug Interactions
1
2013
18
0.440
Why?
Adenocarcinoma
4
2023
1194
0.430
Why?
Class I Phosphatidylinositol 3-Kinases
5
2021
64
0.430
Why?
Hot Temperature
1
2013
208
0.430
Why?
Antimetabolites, Antineoplastic
4
2017
237
0.430
Why?
Information Dissemination
1
2013
113
0.420
Why?
Publishing
1
2013
90
0.420
Why?
Hydroxyurea
12
2014
239
0.410
Why?
Health Status
1
2014
370
0.410
Why?
Adenocarcinoma, Bronchiolo-Alveolar
1
2011
20
0.400
Why?
Surveys and Questionnaires
6
2018
2607
0.400
Why?
Clinical Trials, Phase III as Topic
6
2022
172
0.400
Why?
Carcinoma, Large Cell
1
2011
39
0.400
Why?
Double-Blind Method
7
2021
1713
0.390
Why?
Receptor, ErbB-2
5
2017
238
0.390
Why?
Adenocarcinoma, Follicular
1
2012
54
0.390
Why?
Periodicals as Topic
1
2013
168
0.390
Why?
Radiation-Sensitizing Agents
2
2012
96
0.380
Why?
Benzimidazoles
1
2012
111
0.380
Why?
Sulfonamides
5
2016
317
0.380
Why?
Mitogen-Activated Protein Kinases
3
2008
226
0.380
Why?
Bevacizumab
6
2011
287
0.370
Why?
Patient Care Team
1
2013
283
0.360
Why?
Thyroid Gland
1
2012
280
0.360
Why?
Radiotherapy Dosage
10
2016
470
0.360
Why?
Disease Progression
10
2020
1483
0.350
Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2022
112
0.350
Why?
Receptor Protein-Tyrosine Kinases
2
2011
161
0.340
Why?
Dose-Response Relationship, Drug
10
2017
1938
0.340
Why?
Clinical Trials, Phase II as Topic
4
2022
172
0.340
Why?
Randomized Controlled Trials as Topic
6
2022
832
0.340
Why?
Proto-Oncogene Proteins c-ret
3
2016
23
0.340
Why?
Mice
13
2021
11722
0.340
Why?
Fluorodeoxyglucose F18
1
2010
142
0.340
Why?
Immunohistochemistry
7
2020
1796
0.330
Why?
Diarrhea
4
2014
182
0.330
Why?
Animals
19
2021
27272
0.330
Why?
Protein Kinase C-alpha
1
2009
27
0.330
Why?
Skin
1
2012
581
0.320
Why?
Thalidomide
3
2015
57
0.310
Why?
Proto-Oncogene Proteins B-raf
3
2016
146
0.310
Why?
Radiation Tolerance
4
2016
173
0.310
Why?
Positron-Emission Tomography
1
2010
336
0.310
Why?
Lymphocyte Activation
3
2020
751
0.300
Why?
ras Proteins
3
2016
130
0.300
Why?
Pharmacogenetics
1
2012
443
0.300
Why?
Esophageal Neoplasms
3
2017
332
0.300
Why?
United States
14
2020
6931
0.300
Why?
Radiotherapy
6
2020
331
0.290
Why?
Neoadjuvant Therapy
4
2024
366
0.290
Why?
DNA-Binding Proteins
4
2016
1241
0.290
Why?
Medical Oncology
3
2018
379
0.290
Why?
Chemotherapy, Adjuvant
7
2021
485
0.290
Why?
Young Adult
11
2019
6271
0.280
Why?
Retreatment
5
2015
108
0.280
Why?
Biopsy
3
2020
1180
0.280
Why?
Protein Kinases
1
2008
213
0.280
Why?
Niacinamide
5
2014
115
0.280
Why?
Triazines
1
2007
53
0.280
Why?
DNA, Neoplasm
3
2017
268
0.280
Why?
Eating
1
2007
165
0.270
Why?
Time Factors
9
2020
5313
0.270
Why?
Xenograft Model Antitumor Assays
6
2021
470
0.270
Why?
Retrospective Studies
16
2020
8963
0.270
Why?
Genomics
4
2015
751
0.270
Why?
Epidermal Growth Factor
1
2006
117
0.270
Why?
Immunotoxins
1
2005
14
0.260
Why?
B-Lymphocytes
2
2021
738
0.260
Why?
Apoptosis
5
2023
1715
0.260
Why?
Vascular Endothelial Growth Factor Receptor-2
4
2015
84
0.260
Why?
Deoxycytidine
2
2011
238
0.260
Why?
Oligonucleotides, Antisense
1
2005
68
0.260
Why?
Ribosomal Protein S6 Kinases, 70-kDa
3
2018
46
0.260
Why?
Tongue Neoplasms
3
2017
52
0.260
Why?
Tumor Escape
3
2020
51
0.260
Why?
Immunologic Factors
3
2021
170
0.250
Why?
Viral Vaccines
2
2003
44
0.250
Why?
Protein Kinase C
1
2006
268
0.250
Why?
Drug Approval
2
2019
66
0.250
Why?
United States Food and Drug Administration
2
2019
133
0.250
Why?
Proto-Oncogene Proteins p21(ras)
2
2020
164
0.250
Why?
Fatigue
3
2016
178
0.250
Why?
Risk Factors
11
2019
5448
0.240
Why?
T-Lymphocytes
3
2020
1222
0.240
Why?
Vinblastine
2
2002
108
0.240
Why?
Genes, p53
2
2015
109
0.240
Why?
Phosphatidylinositol 3-Kinases
3
2015
267
0.240
Why?
Evidence-Based Dentistry
3
2017
10
0.230
Why?
Clinical Protocols
2
2014
157
0.230
Why?
Chromosome Deletion
2
2015
229
0.230
Why?
Receptor, ErbB-3
2
2021
20
0.230
Why?
MicroRNAs
1
2009
550
0.230
Why?
Piperazines
3
2017
283
0.230
Why?
Mitochondria
1
2007
551
0.230
Why?
Fluorine
1
2023
17
0.220
Why?
Cell Proliferation
5
2021
1649
0.220
Why?
Deglutition
3
2013
76
0.220
Why?
Smoking
5
2014
620
0.220
Why?
MAP Kinase Signaling System
2
2016
197
0.220
Why?
Platinum
5
2016
63
0.210
Why?
Biomarkers
6
2021
1753
0.210
Why?
Pilot Projects
2
2023
865
0.210
Why?
Alcohol Drinking
4
2013
273
0.210
Why?
Immunomodulation
2
2021
58
0.210
Why?
Follow-Up Studies
10
2018
3649
0.210
Why?
Carboplatin
6
2019
304
0.210
Why?
Pain Management
2
2015
137
0.210
Why?
Lymphocytes, Tumor-Infiltrating
1
2023
129
0.200
Why?
Magnetic Resonance Spectroscopy
1
2023
312
0.200
Why?
Cell Cycle
3
2010
509
0.200
Why?
Neoplasms, Second Primary
3
2011
259
0.200
Why?
Drug Monitoring
2
2019
119
0.200
Why?
Cohort Studies
7
2019
2855
0.200
Why?
Pemetrexed
2
2012
76
0.200
Why?
Adenoviridae
2
2003
349
0.190
Why?
Mechanistic Target of Rapamycin Complex 1
1
2021
29
0.190
Why?
Clinical Competence
2
2018
780
0.190
Why?
Deglutition Disorders
2
2016
119
0.190
Why?
Benzenesulfonates
3
2011
66
0.190
Why?
Germ-Line Mutation
2
2022
343
0.190
Why?
Gene Deletion
2
2014
342
0.190
Why?
Muscle Neoplasms
1
2001
18
0.190
Why?
Immunogenicity, Vaccine
1
2020
13
0.190
Why?
Taxoids
2
2014
130
0.190
Why?
Genetic Therapy
2
2012
369
0.190
Why?
Salvage Therapy
2
2016
235
0.190
Why?
Carcinoma
3
2015
442
0.190
Why?
Immune System
1
2021
97
0.190
Why?
Vaccines, Subunit
1
2020
55
0.180
Why?
Prospective Studies
6
2022
4258
0.180
Why?
Radiotherapy, Intensity-Modulated
3
2019
176
0.180
Why?
Oncolytic Virotherapy
1
2020
42
0.180
Why?
Blood Pressure
3
2014
898
0.180
Why?
Heterografts
2
2017
102
0.180
Why?
Rimantadine
1
2019
9
0.180
Why?
Paclitaxel
6
2012
478
0.180
Why?
Doxorubicin
1
2001
298
0.180
Why?
Quinolones
1
2020
60
0.180
Why?
Oncogene Proteins, Viral
1
2019
34
0.170
Why?
Clinical Trials, Phase I as Topic
3
2014
155
0.170
Why?
Nomograms
1
2019
29
0.170
Why?
Leukoplakia, Oral
2
2024
12
0.170
Why?
Melanoma
1
2024
466
0.170
Why?
Age Factors
3
2019
1862
0.170
Why?
Decision Support Techniques
1
2020
167
0.170
Why?
Models, Immunological
1
2019
81
0.160
Why?
Drug Synergism
3
2018
305
0.160
Why?
CTLA-4 Antigen
1
2019
138
0.160
Why?
Genotype
2
2015
1848
0.160
Why?
Brain Neoplasms
1
2024
780
0.160
Why?
Palliative Medicine
1
2018
11
0.160
Why?
Carcinoma, Neuroendocrine
3
2013
33
0.160
Why?
Chromosomes, Human, Pair 3
2
2015
54
0.160
Why?
Biological Products
1
2020
151
0.150
Why?
Risk Assessment
6
2016
2286
0.150
Why?
Toll-Like Receptor 7
1
2017
8
0.150
Why?
Toll-Like Receptor 9
1
2017
20
0.150
Why?
Immune Tolerance
2
2019
337
0.150
Why?
Cell Growth Processes
2
2009
85
0.150
Why?
Immunoglobulin G
1
2019
463
0.150
Why?
Administration, Intravenous
1
2017
57
0.150
Why?
Transforming Growth Factor alpha
2
2009
50
0.150
Why?
Evidence-Based Medicine
2
2015
430
0.150
Why?
Mouth Mucosa
2
2009
67
0.150
Why?
Confidence Intervals
4
2019
225
0.150
Why?
Consensus
1
2019
355
0.150
Why?
Macrophages
2
2017
570
0.140
Why?
Gene Expression
2
2014
1309
0.140
Why?
Population Surveillance
2
2018
216
0.140
Why?
Models, Biological
3
2014
1763
0.140
Why?
SOX9 Transcription Factor
1
2016
26
0.140
Why?
Mice, Inbred C3H
1
2017
371
0.140
Why?
Urinary Bladder Neoplasms
1
2001
394
0.140
Why?
Class Ib Phosphatidylinositol 3-Kinase
1
2016
4
0.140
Why?
Base Sequence
3
2014
2326
0.140
Why?
Proto-Oncogenes
1
2016
61
0.140
Why?
Pyrazines
2
2022
94
0.140
Why?
Metformin
1
2018
123
0.140
Why?
Predictive Value of Tests
2
2020
1713
0.140
Why?
Accessory Nerve Diseases
1
2016
1
0.140
Why?
Mass Screening
2
2012
631
0.140
Why?
Dental Caries
1
2016
4
0.140
Why?
Trismus
1
2016
6
0.140
Why?
Respiratory Aspiration
1
2016
5
0.140
Why?
Taste Disorders
1
2016
8
0.140
Why?
Xerostomia
1
2016
10
0.140
Why?
Circulating Tumor DNA
1
2017
47
0.140
Why?
Periodontitis
1
2016
7
0.140
Why?
In Situ Hybridization, Fluorescence
3
2012
354
0.140
Why?
Tomography, X-Ray Computed
3
2019
2649
0.140
Why?
Voice Disorders
1
2016
8
0.140
Why?
American Cancer Society
1
2016
13
0.140
Why?
Dental Care
1
2016
12
0.140
Why?
Stomatitis
1
2016
30
0.140
Why?
Bursitis
1
2016
10
0.140
Why?
Osteonecrosis
1
2016
22
0.140
Why?
Benzamides
2
2022
237
0.140
Why?
Vestibular Neuronitis
1
2016
5
0.140
Why?
Neck Muscles
1
2016
17
0.140
Why?
Dystonia
1
2016
29
0.130
Why?
Peptide Hormones
1
2016
29
0.130
Why?
Pyrimidinones
1
2016
37
0.130
Why?
Pyridones
1
2016
55
0.130
Why?
Proto-Oncogene Proteins
2
2010
666
0.130
Why?
Drug Evaluation, Preclinical
1
2015
105
0.130
Why?
Societies, Medical
1
2019
567
0.130
Why?
Peripheral Nervous System Diseases
1
2016
87
0.130
Why?
Matrix Metalloproteinases
1
2015
29
0.130
Why?
Collagen Type I
1
2015
72
0.130
Why?
Drug Screening Assays, Antitumor
2
2015
78
0.120
Why?
Pneumonia, Aspiration
1
2014
19
0.120
Why?
Receptors, IgG
1
2015
53
0.120
Why?
Sleep Apnea Syndromes
1
2016
106
0.120
Why?
Multivariate Analysis
3
2019
986
0.120
Why?
Lymphedema
1
2016
77
0.120
Why?
Sleep Wake Disorders
1
2016
116
0.120
Why?
Proteomics
2
2022
230
0.120
Why?
Cost-Benefit Analysis
2
2020
461
0.120
Why?
Phosphorylation
2
2018
1128
0.120
Why?
Stomach Neoplasms
1
2017
281
0.120
Why?
Ubiquitin-Activating Enzymes
1
2014
6
0.120
Why?
Health Promotion
1
2016
163
0.120
Why?
Autophagy-Related Protein 7
1
2014
12
0.120
Why?
Drug Interactions
3
2011
245
0.120
Why?
Sequestosome-1 Protein
1
2014
22
0.120
Why?
Education, Medical, Graduate
1
2018
390
0.120
Why?
Tumor Virus Infections
1
2014
81
0.120
Why?
Heterocyclic Compounds, 3-Ring
1
2014
30
0.120
Why?
Gastroesophageal Reflux
1
2016
122
0.120
Why?
Hypothyroidism
1
2016
235
0.120
Why?
Neoplasm Grading
1
2015
372
0.120
Why?
Peptide Fragments
1
2016
461
0.120
Why?
Pediatrics
1
2018
351
0.120
Why?
Quinoxalines
1
2014
50
0.120
Why?
Licensure
1
2013
6
0.110
Why?
Tissue Array Analysis
1
2014
127
0.110
Why?
Transcription Factors
2
2016
1650
0.110
Why?
DNA Primers
2
2014
543
0.110
Why?
Population Groups
1
2013
41
0.110
Why?
Anxiety
1
2016
307
0.110
Why?
Focus Groups
1
2014
168
0.110
Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
2
2013
75
0.110
Why?
Peer Review
1
2013
23
0.110
Why?
Aminolevulinic Acid
1
2013
22
0.110
Why?
Regression Analysis
2
2019
590
0.110
Why?
CD8-Positive T-Lymphocytes
1
2017
592
0.110
Why?
Erythropoiesis
1
2013
51
0.110
Why?
Statistics, Nonparametric
3
2009
306
0.110
Why?
Photosensitizing Agents
1
2013
50
0.110
Why?
Economics, Pharmaceutical
1
2013
10
0.110
Why?
Area Under Curve
5
2014
337
0.110
Why?
Interviews as Topic
1
2014
334
0.110
Why?
Breast Neoplasms
2
2017
2991
0.110
Why?
Italy
1
2013
107
0.110
Why?
Magnetics
1
2013
41
0.110
Why?
Micelles
1
2013
48
0.110
Why?
Antineoplastic Agents, Phytogenic
2
2012
277
0.110
Why?
United Kingdom
1
2013
163
0.110
Why?
Stress, Psychological
1
2016
321
0.110
Why?
Gastrostomy
1
2013
69
0.110
Why?
Citrus paradisi
1
2012
5
0.110
Why?
Qualitative Research
1
2014
289
0.110
Why?
Photochemotherapy
1
2013
100
0.110
Why?
Gene Expression Profiling
3
2014
1428
0.110
Why?
Ketoconazole
1
2012
26
0.110
Why?
Magnetic Resonance Imaging
2
2023
3441
0.110
Why?
Lymphopenia
1
2012
31
0.100
Why?
Colorectal Neoplasms
2
2011
980
0.100
Why?
Dose-Response Relationship, Radiation
2
2009
188
0.100
Why?
Sexual Partners
1
2013
99
0.100
Why?
Platinum Compounds
1
2012
31
0.100
Why?
Autophagy
1
2014
154
0.100
Why?
Pyrimidines
2
2014
372
0.100
Why?
Intracellular Signaling Peptides and Proteins
1
2014
387
0.100
Why?
Biopsy, Needle
1
2012
233
0.100
Why?
DNA Repair
1
2014
361
0.100
Why?
Hyperlipidemias
1
2012
92
0.100
Why?
Depression
1
2016
502
0.100
Why?
RNA, Viral
1
2013
314
0.100
Why?
Peptides
1
2015
646
0.100
Why?
Radiography
2
2014
809
0.100
Why?
Tumor Suppressor Protein p53
1
2014
409
0.100
Why?
Bibenzyls
1
2011
2
0.100
Why?
Exanthema
1
2012
39
0.100
Why?
RNA, Small Interfering
2
2010
557
0.100
Why?
Lactams, Macrocyclic
1
2011
14
0.100
Why?
Radiotherapy, Adjuvant
3
2008
295
0.100
Why?
Nanoparticles
1
2013
164
0.100
Why?
Benzoquinones
1
2011
27
0.100
Why?
Feasibility Studies
2
2019
778
0.100
Why?
Valproic Acid
1
2011
24
0.100
Why?
Depsipeptides
1
2011
30
0.100
Why?
Hyperglycemia
1
2012
172
0.100
Why?
Tracheotomy
1
2011
18
0.100
Why?
Hydroxamic Acids
1
2011
51
0.100
Why?
Carbazoles
1
2011
33
0.090
Why?
Boronic Acids
1
2011
56
0.090
Why?
Bortezomib
1
2011
82
0.090
Why?
In Situ Nick-End Labeling
1
2011
122
0.090
Why?
Imatinib Mesylate
1
2011
127
0.090
Why?
HSP90 Heat-Shock Proteins
1
2011
46
0.090
Why?
Gene Expression Regulation, Neoplastic
3
2024
1265
0.090
Why?
Psoriasis
1
2014
245
0.090
Why?
Oligonucleotides
1
2011
92
0.090
Why?
Chemoprevention
1
2011
92
0.090
Why?
Histone Deacetylase Inhibitors
1
2011
92
0.090
Why?
Cyclin D1
1
2010
84
0.090
Why?
Camptothecin
1
2011
193
0.090
Why?
Neoplasm Transplantation
1
2011
397
0.090
Why?
Probability
5
2009
353
0.090
Why?
Sexual Behavior
1
2013
308
0.090
Why?
Speech
1
2010
85
0.090
Why?
Airway Obstruction
1
2011
110
0.090
Why?
Piperidines
1
2011
164
0.090
Why?
DNA Mutational Analysis
2
2015
529
0.090
Why?
Antigen-Presenting Cells
2
2021
141
0.090
Why?
Cell Cycle Proteins
2
2010
401
0.080
Why?
Transplantation, Heterologous
1
2010
370
0.080
Why?
Thermography
1
2009
14
0.080
Why?
Tumor Cells, Cultured
1
2011
1057
0.080
Why?
Mass Spectrometry
1
2010
193
0.080
Why?
Receptors, Growth Factor
1
2009
52
0.080
Why?
Cell Line
2
2011
2494
0.080
Why?
Cyclin E
1
2009
28
0.080
Why?
Biomedical Research
1
2013
397
0.080
Why?
Endpoint Determination
1
2009
61
0.080
Why?
Referral and Consultation
1
2012
341
0.080
Why?
Demography
1
2009
181
0.080
Why?
Radiotherapy, High-Energy
1
2008
49
0.080
Why?
Internship and Residency
1
2018
1040
0.080
Why?
Cell Survival
1
2011
981
0.080
Why?
Adolescent
6
2019
9201
0.080
Why?
Oligonucleotide Array Sequence Analysis
1
2010
695
0.080
Why?
Amino Acid Sequence
2
2016
2061
0.080
Why?
Radiosurgery
1
2011
280
0.080
Why?
Research
1
2009
252
0.080
Why?
Analysis of Variance
2
2008
901
0.080
Why?
Economics, Medical
1
2007
6
0.080
Why?
Drug Packaging
1
2007
7
0.070
Why?
Drug Labeling
1
2007
41
0.070
Why?
Molecular Sequence Data
2
2016
3026
0.070
Why?
Polymorphism, Genetic
1
2011
824
0.070
Why?
DNA, Mitochondrial
1
2007
187
0.070
Why?
Carcinoma, Renal Cell
1
2011
434
0.070
Why?
DNA
1
2012
1307
0.070
Why?
Benzophenanthridines
1
2006
23
0.070
Why?
Butadienes
1
2006
34
0.070
Why?
Phenanthridines
1
2006
24
0.070
Why?
Phosphorylcholine
1
2006
28
0.070
Why?
Alkaloids
1
2006
46
0.070
Why?
Remission Induction
3
2016
738
0.070
Why?
Phenotype
1
2012
2439
0.070
Why?
Surgical Flaps
1
2008
249
0.070
Why?
Nitriles
1
2006
160
0.070
Why?
American Dental Association
2
2017
9
0.060
Why?
Early Detection of Cancer
3
2017
411
0.060
Why?
Keratinocytes
1
2006
145
0.060
Why?
Kidney Neoplasms
1
2011
634
0.060
Why?
Preoperative Care
2
2006
395
0.060
Why?
Cyclooxygenase Inhibitors
1
2004
39
0.060
Why?
Enzyme Activation
1
2006
698
0.060
Why?
Proteasome Inhibitors
1
2004
52
0.060
Why?
SEER Program
2
2016
197
0.060
Why?
Hypoxia-Inducible Factor 1
1
2004
43
0.060
Why?
Incidence
3
2017
1591
0.060
Why?
Mouthwashes
1
2003
5
0.060
Why?
Cell Transformation, Neoplastic
1
2006
447
0.060
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2004
155
0.060
Why?
DNA Copy Number Variations
2
2015
177
0.060
Why?
Colonic Neoplasms
1
2008
573
0.060
Why?
Mitogen-Activated Protein Kinase 3
1
2003
71
0.060
Why?
Vascular Endothelial Growth Factor Receptor-3
2
2015
27
0.060
Why?
Intubation, Gastrointestinal
1
2003
31
0.060
Why?
CCAAT-Enhancer-Binding Protein-beta
2
2016
13
0.060
Why?
Disease Models, Animal
2
2020
2347
0.050
Why?
Infant
2
2023
3130
0.050
Why?
Odds Ratio
2
2018
684
0.050
Why?
Infusions, Intravenous
3
2009
434
0.050
Why?
Vascular Endothelial Growth Factor Receptor-1
2
2015
94
0.050
Why?
Isotretinoin
1
2002
23
0.050
Why?
Gene Amplification
2
2015
134
0.050
Why?
Inflammation
2
2019
969
0.050
Why?
Medicare
2
2016
422
0.050
Why?
Illinois
1
2003
472
0.050
Why?
Sex Factors
2
2014
1062
0.050
Why?
Cytodiagnosis
2
2012
44
0.050
Why?
Germany
1
2021
72
0.050
Why?
Interferon-alpha
1
2002
226
0.050
Why?
Lymphopoiesis
1
2021
48
0.050
Why?
Antibody Formation
1
2021
171
0.050
Why?
Structure-Activity Relationship
1
2001
411
0.050
Why?
Placebos
1
2021
214
0.050
Why?
Urothelium
1
2001
71
0.050
Why?
Standard of Care
1
2021
65
0.050
Why?
RAW 264.7 Cells
1
2019
16
0.040
Why?
Nuclear Proteins
1
2004
725
0.040
Why?
Treatment Adherence and Compliance
1
2019
5
0.040
Why?
Models, Economic
1
2020
62
0.040
Why?
Child
3
2018
7113
0.040
Why?
Thinness
1
2019
44
0.040
Why?
Employment
1
2019
53
0.040
Why?
Receptors, Cytokine
1
2019
28
0.040
Why?
Smokers
1
2019
46
0.040
Why?
Patient Reported Outcome Measures
1
2021
190
0.040
Why?
Quality-Adjusted Life Years
1
2020
142
0.040
Why?
Healthy Volunteers
1
2019
145
0.040
Why?
Histocompatibility Antigens Class II
1
2019
164
0.040
Why?
Hospitals, Veterans
1
2018
21
0.040
Why?
Veterans
1
2019
83
0.040
Why?
Equivalence Trials as Topic
1
2018
6
0.040
Why?
Epithelial Cells
1
2022
688
0.040
Why?
Training Support
1
2018
23
0.040
Why?
Interdisciplinary Studies
1
2018
20
0.040
Why?
Insulin-Like Growth Factor II
1
2018
33
0.040
Why?
Antigen Presentation
1
2019
215
0.040
Why?
Laryngectomy
1
2018
26
0.040
Why?
Organ Specificity
1
2019
272
0.040
Why?
Clinical Decision-Making
1
2020
279
0.040
Why?
Down-Regulation
1
2019
519
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
201
0.040
Why?
Herpesvirus 1, Human
1
2020
243
0.040
Why?
Mouth
1
2017
48
0.040
Why?
Enteral Nutrition
1
2018
102
0.040
Why?
Insulin-Like Growth Factor I
1
2018
114
0.040
Why?
HEK293 Cells
1
2019
638
0.040
Why?
Autoimmunity
1
2019
168
0.040
Why?
Reference Values
2
2009
661
0.040
Why?
Acrylamides
1
2017
32
0.040
Why?
Leukocytes, Mononuclear
1
2018
205
0.040
Why?
Neck Dissection
2
2008
67
0.040
Why?
MDS1 and EVI1 Complex Locus Protein
1
2016
6
0.040
Why?
Diagnostic Tests, Routine
1
2017
64
0.040
Why?
Regulatory-Associated Protein of mTOR
1
2016
11
0.040
Why?
Proportional Hazards Models
1
2019
848
0.040
Why?
Aniline Compounds
1
2017
58
0.040
Why?
Osteonectin
1
2016
22
0.040
Why?
Program Evaluation
1
2018
306
0.040
Why?
National Cancer Institute (U.S.)
1
2016
73
0.030
Why?
MCF-7 Cells
1
2016
114
0.030
Why?
Financing, Government
1
2016
24
0.030
Why?
Decision Making
1
2002
664
0.030
Why?
Immunoenzyme Techniques
1
2016
306
0.030
Why?
Loss of Heterozygosity
1
2016
86
0.030
Why?
Comorbidity
1
2019
947
0.030
Why?
Bayes Theorem
1
2017
368
0.030
Why?
Snake Venoms
1
2015
10
0.030
Why?
Exons
1
2017
451
0.030
Why?
Acid Anhydride Hydrolases
1
2015
13
0.030
Why?
Microfilament Proteins
1
2016
212
0.030
Why?
RNA Interference
1
2016
376
0.030
Why?
Cause of Death
1
2016
266
0.030
Why?
Human papillomavirus 18
1
2014
16
0.030
Why?
Cell Division
1
2016
696
0.030
Why?
Biological Availability
1
2014
92
0.030
Why?
Lymphatic Metastasis
1
2016
502
0.030
Why?
Nonlinear Dynamics
1
2014
73
0.030
Why?
Protein Interaction Maps
1
2014
49
0.030
Why?
Tissue Distribution
1
2014
292
0.030
Why?
Gene Knockout Techniques
1
2014
82
0.030
Why?
Transcription, Genetic
1
2019
1155
0.030
Why?
Anorexia
1
2014
30
0.030
Why?
Metabolic Clearance Rate
1
2014
120
0.030
Why?
Immunoblotting
1
2014
273
0.030
Why?
Erythrocyte Count
1
2013
22
0.030
Why?
Calcitonin
1
2013
38
0.030
Why?
Carcinoembryonic Antigen
1
2013
40
0.030
Why?
Leg
1
2014
140
0.030
Why?
Algorithms
2
2013
1870
0.030
Why?
Cotinine
1
2013
12
0.030
Why?
Receptor, ErbB-4
1
2013
5
0.030
Why?
Erythropoietin
1
2013
88
0.030
Why?
Carrier Proteins
1
2016
680
0.030
Why?
Genetic Association Studies
1
2015
294
0.030
Why?
NF-kappa B
1
2016
465
0.030
Why?
HeLa Cells
1
2014
511
0.030
Why?
Microscopy, Atomic Force
1
2013
53
0.030
Why?
Sensitivity and Specificity
1
2017
2013
0.030
Why?
Pyrazoles
1
2014
150
0.030
Why?
Sequence Analysis, RNA
1
2014
232
0.030
Why?
Risk Reduction Behavior
1
2013
96
0.030
Why?
Tolonium Chloride
1
2012
5
0.030
Why?
Herpesvirus 4, Human
1
2013
119
0.030
Why?
Coloring Agents
1
2012
65
0.030
Why?
Saliva
1
2013
123
0.030
Why?
Vomiting
1
2014
194
0.030
Why?
Microscopy, Confocal
1
2013
276
0.030
Why?
Asymptomatic Diseases
1
2012
45
0.030
Why?
Self Report
1
2013
295
0.020
Why?
Radiotherapy Planning, Computer-Assisted
1
2012
179
0.020
Why?
Supraglottitis
1
2011
3
0.020
Why?
Chemoradiotherapy, Adjuvant
1
2011
35
0.020
Why?
Neoplasm Proteins
1
2015
540
0.020
Why?
Physical Examination
1
2012
148
0.020
Why?
Cells, Cultured
1
2016
2879
0.020
Why?
Light
1
2012
291
0.020
Why?
Radiation Dosage
1
2011
225
0.020
Why?
Cross-Over Studies
1
2011
389
0.020
Why?
Review Literature as Topic
1
2010
21
0.020
Why?
Osteoradionecrosis
1
2010
18
0.020
Why?
Postoperative Period
1
2010
301
0.020
Why?
Mercury Compounds
1
2009
1
0.020
Why?
Cadmium Compounds
1
2009
2
0.020
Why?
Mice, Inbred C57BL
1
2016
3202
0.020
Why?
ROC Curve
1
2012
778
0.020
Why?
Laboratories
1
2009
44
0.020
Why?
Nitrogen
1
2009
73
0.020
Why?
Hospitalization
1
2014
873
0.020
Why?
Tight Junctions
1
2010
150
0.020
Why?
Cyclin D
1
2008
14
0.020
Why?
Gene Dosage
1
2009
208
0.020
Why?
Infant, Newborn
1
2014
2464
0.020
Why?
Transcription Factor AP-1
1
2008
65
0.020
Why?
Rats, Inbred F344
1
2008
154
0.020
Why?
Azoxymethane
1
2008
84
0.020
Why?
Cyclins
1
2008
83
0.020
Why?
Equipment Design
1
2009
415
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2010
887
0.020
Why?
STAT3 Transcription Factor
1
2008
85
0.020
Why?
Technology, Radiologic
1
2008
103
0.020
Why?
Temperature
1
2009
400
0.020
Why?
Organ Preservation
1
2008
105
0.020
Why?
Glioblastoma
1
2010
265
0.020
Why?
Proto-Oncogene Proteins c-met
1
2009
200
0.020
Why?
Child, Preschool
1
2014
3695
0.020
Why?
Transfection
1
2009
911
0.020
Why?
Barrett Esophagus
1
2008
93
0.020
Why?
Protein Structure, Tertiary
1
2009
740
0.020
Why?
Forecasting
1
2008
305
0.020
Why?
Polymorphism, Single Nucleotide
1
2015
2397
0.020
Why?
Blotting, Western
1
2008
794
0.020
Why?
Body Mass Index
1
2009
770
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2006
125
0.020
Why?
Phospholipids
1
2006
111
0.020
Why?
Genome, Human
1
2010
767
0.020
Why?
Pleural Effusion
1
2004
47
0.020
Why?
Organoplatinum Compounds
1
2004
97
0.020
Why?
RNA, Messenger
1
2010
2011
0.010
Why?
Administration, Topical
1
2003
96
0.010
Why?
Membrane Proteins
1
2010
1214
0.010
Why?
In Situ Hybridization
1
2003
313
0.010
Why?
Genome-Wide Association Study
1
2011
1667
0.010
Why?
Survival
1
2002
21
0.010
Why?
Severity of Illness Index
1
2008
1835
0.010
Why?
Rats
1
2008
4039
0.010
Why?
Registries
1
2006
773
0.010
Why?
Case-Control Studies
1
2006
1849
0.010
Why?
Cohen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (656)
Explore
_
Co-Authors (58)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_